Gen Digital Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Gen Digital Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Mar 28, 2014 | $6.68B | May 16, 2014 |
| FY2013 | Mar 29, 2013 | $6.91B | May 16, 2014 |
| FY2013 | Mar 30, 2012 | $6.73B | May 16, 2014 |
| FY2012 | Apr 1, 2011 | $6.19B | May 17, 2013 |
| FY2011 | Apr 2, 2010 | $5.99B | May 21, 2012 |
| FY2010 | Apr 3, 2009 | $6.15B | May 20, 2011 |
| FY2009 | Mar 28, 2008 | $5.87B | May 24, 2010 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $3.94B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $3.80B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $3.32B | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $2.80B | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $2.55B | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $2.49B | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $2.46B | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $2.56B | May 28, 2020 |
| FY2019 | Mar 31, 2017 | $4.02B | May 24, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Mar 31, 2017 | $4.02B | May 19, 2017 |
| FY2017 | Apr 1, 2016 | $3.60B | May 19, 2017 |
| FY2017 | Apr 3, 2015 | $3.96B | May 19, 2017 |
| FY2016 | Mar 28, 2014 | $4.18B | May 20, 2016 |
| FY2015 | Mar 29, 2013 | $6.91B | May 22, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $3.16B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $3.07B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $2.73B | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $2.39B | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $2.19B | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $2.10B | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $2.00B | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $2.10B | May 28, 2020 |
| FY2019 | Mar 31, 2017 | $3.17B | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $2.99B | Oct 26, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $643.00M | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $607.00M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $1.33B | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $836.00M | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $554.00M | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $3.89B | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $31.00M | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $1.14B | May 28, 2020 |
| FY2019 | Mar 31, 2017 | ($106.00M) | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $2.49B | Oct 26, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $1.61B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $1.11B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $1.21B | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $1.01B | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $896.00M | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $355.00M | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $158.00M | May 21, 2021 |
| FY2020 | Mar 30, 2018 | ($154.00M) | May 28, 2020 |
| FY2019 | Mar 31, 2017 | ($100.00M) | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $457.00M | Oct 26, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $329.00M | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $332.00M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $313.00M | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $253.00M | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $267.00M | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $328.00M | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $420.00M | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $455.00M | May 28, 2020 |
| FY2019 | Mar 31, 2017 | $823.00M | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $748.00M | Oct 26, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $1.22B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $2.06B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $757.00M | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $974.00M | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $706.00M | May 25, 2023 |
| FY2022 | Apr 3, 2020 | ($861.00M) | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $1.50B | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $950.00M | May 28, 2020 |
| FY2019 | Mar 31, 2017 | ($209.00M) | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $802.00M | Oct 26, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $15.00M | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $20.00M | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $6.00M | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $6.00M | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $6.00M | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $89.00M | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $207.00M | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $142.00M | May 28, 2020 |
| FY2019 | Mar 31, 2017 | $70.00M | May 24, 2019 |
| FY2018 | Apr 1, 2016 | $272.00M | Oct 26, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $15.50B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $15.79B | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $15.95B | May 16, 2024 |
| FY2023 | Apr 1, 2022 | $6.94B | May 25, 2023 |
| FY2022 | Apr 2, 2021 | $6.36B | May 20, 2022 |
| FY2021 | Apr 3, 2020 | $7.74B | May 21, 2021 |
| FY2020 | Mar 29, 2019 | $15.94B | May 28, 2020 |
| FY2019 | Mar 31, 2018 | $16.57B | May 24, 2019 |
| FY2019 | Mar 30, 2018 | $15.76B | May 24, 2019 |
| FY2018 | Mar 31, 2017 | $18.17B | Oct 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $13.23B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $13.65B | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $13.75B | May 16, 2024 |
| FY2023 | Apr 1, 2022 | $7.04B | May 25, 2023 |
| FY2022 | Apr 2, 2021 | $6.86B | May 20, 2022 |
| FY2021 | Apr 3, 2020 | $7.73B | May 21, 2021 |
| FY2020 | Mar 29, 2019 | $10.20B | May 28, 2020 |
| FY2019 | Mar 31, 2018 | $10.61B | May 24, 2019 |
| FY2019 | Mar 30, 2018 | $10.74B | May 24, 2019 |
| FY2018 | Mar 31, 2017 | $14.69B | Oct 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $2.27B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $2.14B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $2.15B | May 15, 2025 |
| FY2025 | Apr 1, 2022 | ($126.00M) | May 15, 2025 |
| FY2024 | Apr 2, 2021 | ($500.00M) | May 16, 2024 |
| FY2023 | Apr 3, 2020 | $10.00M | May 25, 2023 |
| FY2022 | Mar 29, 2019 | $5.74B | May 20, 2022 |
| FY2021 | Mar 30, 2018 | $5.02B | May 21, 2021 |
| FY2020 | Mar 31, 2017 | $3.49B | May 28, 2020 |
| FY2017 | Apr 1, 2016 | $3.68B | May 19, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $10.24B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $10.21B | May 15, 2025 |
| FY2025 | Mar 31, 2023 | $10.22B | May 15, 2025 |
| FY2024 | Apr 1, 2022 | $2.87B | May 16, 2024 |
| FY2023 | Apr 2, 2021 | $2.87B | May 25, 2023 |
| FY2022 | Apr 3, 2020 | $2.59B | May 20, 2022 |
| FY2021 | Mar 29, 2019 | $2.68B | May 21, 2021 |
| FY2020 | Mar 30, 2018 | $2.67B | May 28, 2020 |
| FY2019 | Mar 31, 2017 | $8.63B | May 24, 2019 |
| FY2019 | Feb 9, 2017 | $5.48B | May 24, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $236.00M | May 15, 2025 |
| FY2025 | Mar 29, 2024 | ($98.00M) | May 15, 2025 |
| FY2024 | Mar 31, 2023 | ($585.00M) | May 16, 2024 |
| FY2023 | Apr 1, 2022 | ($1.94B) | May 25, 2023 |
| FY2022 | Apr 2, 2021 | ($2.78B) | May 20, 2022 |
| FY2021 | Apr 3, 2020 | ($3.33B) | May 21, 2021 |
| FY2020 | Mar 29, 2019 | $933.00M | May 28, 2020 |
| FY2019 | Mar 31, 2018 | $1.27B | May 24, 2019 |
| FY2019 | Mar 30, 2018 | $328.00M | May 24, 2019 |
| FY2018 | Mar 31, 2017 | ($761.00M) | Oct 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $1.01B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $846.00M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $750.00M | May 16, 2024 |
| FY2023 | Apr 1, 2022 | $1.89B | May 25, 2023 |
| FY2022 | Apr 2, 2021 | $933.00M | May 20, 2022 |
| FY2021 | Apr 3, 2020 | $2.18B | May 21, 2021 |
| FY2020 | Mar 29, 2019 | $1.79B | May 28, 2020 |
| FY2019 | Mar 30, 2018 | $1.77B | May 24, 2019 |
| FY2018 | Mar 31, 2017 | $4.25B | Oct 26, 2018 |
| FY2017 | Apr 1, 2016 | $5.98B | May 19, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | $8.26B | May 15, 2025 |
| FY2025 | Mar 29, 2024 | $8.60B | May 15, 2025 |
| FY2024 | Mar 31, 2023 | $9.76B | May 16, 2024 |
| FY2023 | Apr 1, 2022 | $3.74B | May 25, 2023 |
| FY2022 | Apr 2, 2021 | $3.60B | May 20, 2022 |
| FY2021 | Apr 3, 2020 | $4.22B | May 21, 2021 |
| FY2020 | Mar 29, 2019 | $4.45B | May 28, 2020 |
| FY2019 | Mar 30, 2018 | $5.03B | May 24, 2019 |
| FY2018 | Mar 31, 2017 | $8.19B | Oct 26, 2018 |
| FY2017 | Apr 1, 2016 | $2.21B | May 19, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | 1 | May 15, 2025 |
| FY2025 | Mar 29, 2024 | 0 | May 15, 2025 |
| FY2025 | Mar 31, 2023 | 2 | May 15, 2025 |
| FY2024 | Apr 1, 2022 | 1 | May 16, 2024 |
| FY2023 | Apr 2, 2021 | 0 | May 25, 2023 |
| FY2022 | Apr 3, 2020 | 6 | May 20, 2022 |
| FY2021 | Mar 29, 2019 | 0 | May 21, 2021 |
| FY2020 | Mar 30, 2018 | 1 | May 28, 2020 |
| FY2019 | Mar 31, 2017 | 0 | May 24, 2019 |
| FY2018 | Apr 1, 2016 | 3 | Oct 26, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | 1 | May 15, 2025 |
| FY2025 | Mar 29, 2024 | 0 | May 15, 2025 |
| FY2025 | Mar 31, 2023 | 2 | May 15, 2025 |
| FY2024 | Apr 1, 2022 | 1 | May 16, 2024 |
| FY2023 | Apr 2, 2021 | 0 | May 25, 2023 |
| FY2022 | Apr 3, 2020 | 6 | May 20, 2022 |
| FY2021 | Mar 29, 2019 | 0 | May 21, 2021 |
| FY2020 | Mar 30, 2018 | 1 | May 28, 2020 |
| FY2019 | Mar 31, 2017 | 0 | May 24, 2019 |
| FY2018 | Apr 1, 2016 | 3 | Oct 26, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 28, 2025 | 617.00M | May 15, 2025 |
| FY2025 | Mar 29, 2024 | 623.00M | May 15, 2025 |
| FY2024 | Mar 31, 2023 | 640.00M | May 16, 2024 |
| FY2023 | Apr 1, 2022 | 582.00M | May 25, 2023 |
| FY2022 | Apr 2, 2021 | 580.00M | May 20, 2022 |
| FY2021 | Apr 3, 2020 | 589.00M | May 21, 2021 |
| FY2020 | Mar 29, 2019 | 630.00M | May 28, 2020 |
| FY2019 | Mar 30, 2018 | 624.00M | May 24, 2019 |
| FY2018 | Mar 31, 2017 | 608.00M | Oct 26, 2018 |
| FY2017 | Apr 1, 2016 | 612,266 | May 19, 2017 |